
₹14,526(18 Shares)
Minimum Investment
IPO Dates
Aug 10, 2026 – Aug 12, 2026
Price Band
₹768–807 per equity share
Issue Size
₹939.7 Cr
Lot Size
18
Listing
Aug 17, 2026
Listing At
BSE, NSE
NII Sub-Categories
bHNI (> ₹10L)
Bids above ₹10L
sHNI (< ₹10L)
Bids ₹2L to ₹10L
Overall Subscription
Total Bids Received
70.26x
Shares Offered
17,43,860
Shares Offered
23,25,146
Shares Offered
34,87,717
Incorporated in October 2000, Molbio Diagnostics Limited is an international POC (Point of Care) molecular diagnostics company providing the research, development, manufacture, and marketing of rapid ...
EPS (Pre-IPO)
14.56
EPS (Post-IPO)
14.24
P/E (Pre-IPO)
55.43
P/E (Post-IPO)
56.67
RoNW
14.55%
PAT Margin
11.28%
P/B Value
9.55
Market Cap
₹9,299.87 Cr.
* All figures are in ₹ Crores unless otherwise stated.
Plot No. L-46, Phase II-D, Verna Industrial Area, Verna, Salcete, South Goa, Goa, 403722
Kfin Technologies Ltd.
IIFL Capital Services Ltd.
Kotak Mahindra Capital Co.Ltd.
Jefferies India Pvt.Ltd.
Motilal Oswal Investment Advisors Ltd.
The Molbio Diagnostics IPO price band is set at ₹768.00 to ₹807.00 per equity share.
The total issue size of Molbio Diagnostics IPO is ₹939.7 Cr.
The lot size for Molbio Diagnostics IPO is 18 shares per lot. The minimum investment amount is approximately ₹14,526.
The Molbio Diagnostics IPO opens on Aug 10, 2026 and closes on Aug 12, 2026.
The basis of allotment for Molbio Diagnostics IPO is expected to be finalized on Aug 13, 2026.
Molbio Diagnostics IPO is expected to be listed on Aug 17, 2026 on BSE, NSE.
The current GMP for Molbio Diagnostics IPO is ₹120, suggesting an expected listing price of around ₹888.00. Note: GMP is an unofficial market indicator.
The registrar for Molbio Diagnostics IPO is Kfin Technologies Ltd.. You can contact them at molbio.ipo@kfintech.com.